Monitoring the response to Cushing's treatment is essential for ensuring both efficacy and safety, as the margin between adequate and dangerous cortisol suppression can be narrow.
Cushing's treatment monitoring is a welfare necessity because the narrow therapeutic window means both under-treatment (continued disease symptoms) and over-treatment (acute cortisol crisis) cause significant welfare harm. A dog receiving adequate treatment experiences the welfare benefit of normalizing cortisol levels — restored energy, healthier skin, normal water intake, and weight stabilization. A dog in acute cortisol deficiency crisis from over-treatment is in a life-threatening emergency. The monitoring visits that seem routine are the welfare checkpoints that keep the dog in the beneficial therapeutic range.